1.Targeting lipophagy and nuclear receptors in metabolic-associated fatty liver disease: insights from traditional Chinese medicine

Yue, T, Huang, NF, Z     More...

Yue, T, Huang, NF, Zhao, ZM, Yu, LL, He, XM, Yu, X, Zheng, Y     Less

FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2026, Volume 16,

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2025影響因子:  5.4 

2.Investigating the role of IGF-1 in diabetic gastroparesis: a preliminary review (vol 63, pg 163, 2026)

Lu, YF, Wei, W, Chen     More...

Lu, YF, Wei, W, Chen, H, Xie, YX, Tian, J, Zhao, ZM, Wu, QB, Zhou, XQ     Less

ACTA DIABETOLOGICA[0940-5429], Published 2026,

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2025影響因子:  3.1 

3.Hybrid Cell Membrane-Coated NIR-Photodegradable Carbon Nitride Nanozymes for Mangiferin Dual-Targeted Delivery and Gas Mild Photothermal Immunotherapy Against Liver Fibrosis via the HIF-1α/HSP27 Axis

Liu, MX, Yang, Y, Zh     More...

Liu, MX, Yang, Y, Zhao, XR, Zhang, SY, Cai, YT, Zhang, N, Wang, J, Xu, KY, Zhao, ZM, Wu, QB     Less

CARBON NEUTRALIZATION[2769-3333], Published 2026, Volume 5, Issue 4,

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2025影響因子:  21.5 

4.AIM2 Lactylation Regulates Radiotherapy Sensitivity in Triple-Negative Breast Cancer

Chen, JL, Zhao, ZM,     More...

Chen, JL, Zhao, ZM, Xing, YY, Li, XR, Liu, D, Liu, LJ, Yang, MY, Zhou, H, Wang, J, Wu, QB     Less

BREAST CANCER-TARGETS AND THERAPY[1179-1314], Published 2026, Volume 18,

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2025影響因子:  3.6 

5.The Application and Advancement of Herbal Medicine in Gastrointestinal Cancers: A Bibliometrix Visualization and Pan-cancer Analysis

Zhao, LY, Wang, H, J     More...

Zhao, LY, Wang, H, Jiang, YC, Zhao, ZM, Liang, QY, Li, Y, Wang, J, Zhong, WW, Xu, Y, Zeng, XT, Liu, TR, Yang, YQ, Wu, QB, Xu, KY     Less

CURRENT ONCOLOGY REPORTS[1523-3790], Published 2026, Volume 28, Issue 1,

收錄情况： WOS SCOPUS

WOS核心合集引用: 0  2025影響因子:  5.2 

6.Lingguizhugan Decoction in the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Lu, Yifan, Nie, Liju     More...

Lu, Yifan, Nie, Lijuan, Yang, Xinyi, Zhao, Ziming, Wang, Yuxiao, Wu, Qibiao, Zhou, Xiqiao     Less

Endocrine, Metabolic & Immune Disorders - Drug Targets[1871-5303], Published 2025, Volume 25, Issue 13, Pages 1060-1072

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2025影響因子:  2.0  发表年影響因子:  2.0 

7.Harnessing phytochemicals: Innovative strategies to enhance cancer immunotherapy

Zhu, Qianru, Zhang,     More...

Zhu, Qianru, Zhang, Ruonan, Zhao, Ziming, Xie, Tian, Sui, Xinbing     Less

Drug Resistance Updates[1368-7646], Published 2025, Volume 79,

收錄情况： WOS SCOPUS

WOS核心合集引用: 26  2025影響因子:  22.0  发表年影響因子:  22.0 

8.Linking Hyperuricemia to Cancer: Emerging Evidence on Risk and Progression

Zhao, LY, Guo, RH, Z     More...

Zhao, LY, Guo, RH, Zhao, ZM, Wang, J, Lou, ZH, Bao, JF, Zheng, W, Wang, Q, Qiao, L, Ye, Y, Kwan, HY, Zhou, H, Wu, QB, Xu, KY     Less

CURRENT ONCOLOGY REPORTS[1523-3790], Published 2025,

收錄情况： WOS SCOPUS

WOS核心合集引用: 4  2025影響因子:  5.2  发表年影響因子:  5.2 

9.Identification of Quercetin as a Natural MMP1 Inhibitor for Overcoming Cisplatin Resistance in Epithelial Ovarian Cancer

Wang, SB, Zhao, ZM,     More...

Wang, SB, Zhao, ZM, Yu, LL, Wang, J, Yue, OY, Zhou, H, Shen, WX, Wu, QB     Less

Journal of Cancer[1837-9664], Published 2025, Volume 16, Issue 8, Pages 2578-2594

收錄情况： WOS SCOPUS

WOS核心合集引用: 3  2025影響因子:  3.4  发表年影響因子:  3.4 

10.Tumor Cell Membrane-Coated Oxygen-Evolving Carbon Nitride Nanozymes Combined with Curcumenol Delivery for Lung Cancer Therapy via ‘Open-Source Throttling' Strategy

Liu, MX, Cai, YT, Ya     More...

Liu, MX, Cai, YT, Yang, Y, Zhao, ZM, Wang, J, Xu, KY, Liu, YX, Wu, QB     Less

Advanced Healthcare Materials[2192-2640], Published 2025,

收錄情况： WOS SCOPUS

WOS核心合集引用: 10  2025影響因子:  11.0  发表年影響因子:  11.0 

More...